High reinforcing efficacy of nicotine in non-human primates

PLoS ONE

Volumn 2, Issue 2, 2007, Pages

  Le Foll, Bernard ^a,b   Wertheim, Carrie ^a   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NICOTINE;

ANIMAL BEHAVIOR; ARTICLE; BEHAVIORAL SCIENCE; CONDITIONING; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; MALE; MOTIVATION; NONHUMAN; REINFORCEMENT; SQUIRREL MONKEY; STIMULUS RESPONSE; TOBACCO DEPENDENCE; ANIMAL; CEBIDAE; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SUBSTANCE ABUSE;

ANIMALIA; NICOTIANA TABACUM; PRIMATES; SAIMIRI;

ANIMALS; CONDITIONING, OPERANT; EXTINCTION, PSYCHOLOGICAL; INJECTIONS, INTRAVENOUS; MOTIVATION; NICOTINE; PHOTIC STIMULATION; REINFORCEMENT (PSYCHOLOGY); SAIMIRI; SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS; TOBACCO USE DISORDER;

EID: 36749077282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000230     Document Type: Article

References (61)

1. Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12: 467-473.
2. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, et al. (2000) Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Service. Public Health Service.
3. Robinson JH, Pritchard WS (1992) The role of nicotine in tobacco use. Psychopharmacology (Berl) 108: 397-407.
4. West R (1992) Nicotine addiction: a re-analysis of the arguments. Psychopharmacology (Berl) 108: 408-410; discussion 411-406.
5. Dar R, Frenk H (2002) Nicotine self-administration in animals: a reevaluation. Addict Res Theory 10: 545-579.
6. Dar R, Frenk H (2004) Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology (Berl) 173: 18-26.
7. Perkins KA (2004) Response to Dar and Frenk (2004), "Do smokers self-administer pure nicotine? A review of the evidence". Psychopharmacology (Berl) 175: 256-258; author reply 259-261.
8. Goldberg SR, Panlilio LV, Harvey DM, Yasar S, Heishman SJ, et al. (2005) Nicotine may reinforce intravenous drug-taking behavior in drug users: reply to R. Dar and H. Frenk. Psychopharmacology (Berl).
9. Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1: 11-20.
10. Villegier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, et al. (2006) Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31: 1704-1713.
11. Le Foll B, Goldberg SR (2005) Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) 178: 481-492.
12. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, et al. (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl) 169: 68-76.
13. Belluzzi JD, Wang R, Leslie FM (2004) Acetaldehyde Enhances Acquisition of Nicotine Self-Administration in Adolescent Rats. Neuropsychopharmacology.
14. Goldberg SR, Spealman RD, Goldberg DM (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214: 573-575.
15. Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, et al. (2002) Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 77: 683-687.
16. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, et al. (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70: 515-530.
17. Cohen C, Perrault G, Griebel G, Soubrie P (2005) Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB(1)) Receptor Antagonist, Rimonabant (SR141716). Neuropsychopharmacology 30: 145-155.
18. Le Foll B, Goldberg SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology(Berl) 184: 367-381.
19. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, et al. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733-736.
20. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, et al. (1996) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A 93: 14065-14069.
21. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, et al. (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25: 8593-8600.
22. Agatsuma S, Lee M, Zhu H, Chen K, Shih JC, et al. (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet 15: 2721-2731.
23. Goldberg SR (1973) Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther 186: 18-30.
24. Spear DJ, Muntaner C, Goldberg SR, Katz JL (1991) Methohexital and cocaine self-administration under fixed-ratio and second-order schedules. Pharmacol Biochem Behav 38: 411-416.
25. Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3: 1073-1074.
26. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl) 169: 135-140.
27. Manzardo AM, Stein L, Belluzzi JD (2002) Rats prefer cocaine over nicotine in a two-lever self-administration choice test. Brain Res 924: 10-19.
28. Harvey DM, Yasar S, Heishman SJ, Panlilio LV, Henningfield JE, et al. (2004) Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl) 175: 134-142.
29. Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50: 20-28.
30. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, et al. (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147: 135-142.
31. Donny EC, Caggiula AR, Rowell PP, Gharib MA, Maldovan V, et al. (2000) Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology (Berl) 151: 392-405.
32. Markou A, Paterson NE, Semenova S (2004) Role of {gamma}-Aminobutyric Acid (GABA) and Metabotropic Glutamate Receptors in Nicotine Reinforcement: Potential Pharmacotherapies for Smoking Cessation. Ann N Y Acad Sci 1025: 491-503.
33. Paterson NE, Froestl W, Markou A (2004) The GABA(B) receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172: 179-186.
34. Le Foll B, Goldberg SR (2005) Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol Sci 26: 287-293.
35. Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Garattimi ECaS, ed. Amphetamines and related compounds. New York: Raven. pp. 781-795.
36. Olausson P, Jentsch JD, Taylor JR (2004) Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl) 171: 173-178.
37. Olausson P, Jentsch JD, Taylor JR (2003) Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 28: 1264-1271.
38. Samaha AN, Robinson TE (2005) Why does the rapid delivery of drugs to the brain promote addiction? Trends Pharmacol Sci 26: 82-87.
39. Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal self-administration procedures: psychomotor stimulants and hallucinogens. In: Thompson T, Dews PB, eds. Advances in Behavioral Pharmacology. New York: Academic Press. pp. 163-208.
40. Ator NA, Griffiths RR (1983) Nicotine self-administration in baboons. Pharmacol Biochem Behav 19: 993-1003.
41. Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223: 402-408.
42. Wakasa Y, Takada K, Yanagita T (1995) Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi 15: 53-59.
43. Henningfield JE, Goldberg SR (1983) Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav 19: 1021-1026.
44. Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983) Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 19: 1011-1020.
45. Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234: 1-12.
46. Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, et al. (1996) Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) 128: 221-226.
47. Garrett BE, Griffiths RR (2001) Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther 296: 486-494.
48. Laviolette SR, Van Der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8: 50-59.
49. Grigson PS (1997) Conditioned taste aversions and drugs of abuse: a reinterpretation. Behav Neurosci 111: 129-136.
50. Glowa JR, Barrett JE (1983) Drug history modifies the behavioral effects of pentobarbital. Science 220: 333-335.
51. Le Foll B, Wiggins M, Goldberg SR (2006) Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats. Behav Pharmacol 17: 195-199.
52. Le Foll B, Sokoloff P, Stark H, Goldberg SR (2005) Dopamine D3 ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30: 720-730.
53. Le Foll B, Goldberg SR, Sokoloff P (2005) Dopamine D3 receptor and drug dependence: effect on reward or beyond? Neuropharmacology 49: 525-541.
54. 1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15: 2139-2143.
55. 1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312: 875-883.
56. Roberts DC, Bennett SA (1993) Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 111: 215-218.
57. Deneau GA, Inoki R (1967) Nicotine self-administration in monkeys. Ann N Y Acad Sci. 142: 277-279.
58. Yanagita T (1977) Brief review on the use of self-administration techniques for predicting drug dependence potential. In: Thompson T, Unna KR, eds. Predicting Dependence Liability of Stimulant and Depressant Drugs. Baltimore: Baltimore University Park Press. pp. 231-242.
59. Slifer BL, Balster RL (1985) Intravenous self-administration of nicotine: with and without schedule-induction. Pharmacol Biochem Behav 22: 61-69.
60. de la Garza R, Johanson CE (1987) The effects of food deprivation on the self-administration of psychoactive drugs. Drug Alcohol Depend 19: 17-27.
61. Sannerud CA, Prada J, Goldberg DM, Goldberg SR (1994) The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. Eur J Pharmacol 271: 461-469.